These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9240865)

  • 21. Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudine. Pediatric AIDS Clinical Trials Group 185 Team.
    Lambert JS; Watts DH; Mofenson L; Stiehm ER; Harris DR; Bethel J; Whitehouse J; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H; van Dyke R; Maupin R; Silio M; Fowler MG
    AIDS; 2000 Jul; 14(10):1389-99. PubMed ID: 10930154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
    Sibiude J; Le Chenadec J; Bonnet D; Tubiana R; Faye A; Dollfus C; Mandelbrot L; Delmas S; Lelong N; Khoshnood B; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Jul; 61(2):270-80. PubMed ID: 25838291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Birth Outcomes for Pregnant Women with HIV Using Tenofovir-Emtricitabine.
    Rough K; Seage GR; Williams PL; Hernandez-Diaz S; Huo Y; Chadwick EG; Currier JS; Hoffman RM; Barr E; Shapiro DE; Patel K;
    N Engl J Med; 2018 Apr; 378(17):1593-1603. PubMed ID: 29694825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perinatal exposure to zidovudine--benefits and risks.
    Mofenson LM
    N Engl J Med; 2000 Sep; 343(11):803-5. PubMed ID: 10984571
    [No Abstract]   [Full Text] [Related]  

  • 26. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
    Sturt AS; Dokubo EK; Sint TT
    Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
    Baroncelli S; Pinnetti C; Genovese O; Tamburrini E; Floridia M
    J Med Virol; 2011 Mar; 83(3):551-6. PubMed ID: 21264878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal and obstetric complications among HIV-infected women treated with highly active antiretroviral treatment at a Regional Hospital in Durban, South Africa.
    Sebitloane HM; Moodley J
    Niger J Clin Pract; 2017 Nov; 20(11):1360-1367. PubMed ID: 29303121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zidovudine use in pregnancy: a report on 104 cases and the occurrence of birth defects.
    Kumar RM; Hughes PF; Khurranna A
    J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1034-9. PubMed ID: 8083821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
    Briand N; Le Coeur S; Traisathit P; Karnchanamayul V; Hansudewechakul R; Ngampiyasakul C; Bhakeecheep S; Ithisukanan J; Hongsiriwon S; McIntosh K; Lallemant M
    Pediatr Infect Dis J; 2006 Apr; 25(4):325-32. PubMed ID: 16567984
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM; Sperling RS; Gelber R; Kiselev P; Scott G; O'Sullivan MJ; VanDyke R; Bey M; Shearer W; Jacobson RL
    N Engl J Med; 1994 Nov; 331(18):1173-80. PubMed ID: 7935654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children.
    El Beitune P; Duarte G; Quintana SM; Figueiró-Filho EA; Marcolin AC; Abduch R
    Braz J Infect Dis; 2004 Apr; 8(2):140-50. PubMed ID: 15361992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11).
    Sibiude J; Mandelbrot L; Blanche S; Le Chenadec J; Boullag-Bonnet N; Faye A; Dollfus C; Tubiana R; Bonnet D; Lelong N; Khoshnood B; Warszawski J
    PLoS Med; 2014 Apr; 11(4):e1001635. PubMed ID: 24781315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lopinavir/ritonavir in pregnancy.
    Roberts SS; Martinez M; Covington DL; Rode RA; Pasley MV; Woodward WC
    J Acquir Immune Defic Syndr; 2009 Aug; 51(4):456-61. PubMed ID: 19381099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.
    Ephross SA; Sinclair SM
    Headache; 2014; 54(7):1158-72. PubMed ID: 24805878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prenatal zidovudine use and congenital anomalies in a medicaid population.
    Newschaffer CJ; Cocroft J; Anderson CE; Hauck WW; Turner BJ
    J Acquir Immune Defic Syndr; 2000 Jul; 24(3):249-56. PubMed ID: 10969349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating HIV during pregnancy: an update on safety issues.
    Watts DH
    Drug Saf; 2006; 29(6):467-90. PubMed ID: 16752931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.